Cultivating connections and conversations for biopharma communicators
Welcome to Ticket to Biotech (T2B) – where biopharma communicators of all kinds converge for networking, sharing insights and fostering camaraderie. Plug into our hub, celebrate those "in-the-trenches" tales and connect with peers who truly get it. 2024 programming is free!
© 2024 Ticket to Biotech. All rights reserved.
T2B PRIVACY POLICY
ABOUT T2B
Many comms practitioners are natural conveners. But we don’t always do a good job convening ourselves.That's where Ticket to Biotech (T2B) comes in. T2B is a communicator community with a mission to cultivate connections and conversations. Launched in October 2023 by Lynnea Olivarez, we bring together experienced and emerging life science comms practitioners to address our distinctive challenges by sharing on-the-job insights and resources, learning from each other, and in turn, improving our craft while paying it forward to the next generation.T2B’s 2024 programming is free and includes weekly community discussion topics in a private Slack workspace, press panels and media Q&As, monthly fireside chats with various subject-matter experts, and peer-coaching groups. We currently have 260+ members and continue to expand in support of biopharma communicators globally.Our goal is for T2B to be a space where you feel comfortable asking questions and imparting your own thoughts and perspectives, regardless of where or for whom you may work. Follow our community on LinkedIn, subscribe to our monthly emails, and if you’re a comms professional in our industry, join us. Whether you’re here to express your ideas or simply listen, we welcome you to T2B.
OUR STORY
I got hooked early.I've been a life science communicator for my whole career, supporting all stages of drug development and a variety of biopharma firms along the way.Although I've been incredibly privileged to build a durable support network, there've been so many other amazing comms pros in our niche field who I've wanted to meet and learn from. As I began to attain seniority, myself, more and more connections started asking me to share learnings, guidance and sometimes simple how-to's, too (for ex., what's with all the "potentially's"?).
Despite valuable experiences with the preeminent cell and gene therapy society and national PR association, it became abundantly clear that comms practitioners in our industry face unique challenges: Operating in a highly regulated environment while simultaneously striving to develop strategies that reflect the innovation biopharma is known for.To address this catch-22, I launched T2B, a dedicated space for our corner of comms. In addition to bringing fellow biopharma communicators together for a continuous, open dialogue, T2B provides a spectrum of networking and professional development offerings.I hope that joining our community will be as enriching for you as creating it has been for me. Thank you for coming aboard and being a part of this journey!
T2B Partnerships
All Ticket to Biotech community members are eligible for a 20% discount to Fierce Pharma's 2024 West Coast and East Coast PR & Communications Summits. Check the #announcements channel in Slack for our promo code.
We’re also teaming up with Fierce to take their Rising Stars program up a notch. Accepted participants will receive complimentary admission to the Fierce Pharma PR & Communications Summit—East Coast in July, Jersey City. (Applications for Fierce West are closed.).🌟 This annual program is designed to grow the biopharma PR & communications community, welcome new members, and encourage personal and professional growth and mentorship within the industry.
🆕 Rising Stars will have access to special programming and professional development opportunities designed to turbocharge your summit experience.📌 If you’re an aspiring or early-career communicator with <5 years of experience, we invite you to apply. Feel free to share this info with folks in your network who may benefit from this experience.➡ Learn more and apply here.
Supporting T2B
Our currently available sponsorship opportunities are for T2Bmeet @ BIO, the next in our series of popular, in-person breakfast mixers.
What to know:
More than half of T2B’s 260 members cited networking/idea exchange as their #1 reason for joining our community.
At the time of our first T2Bmeet @ JPM in January, our breakfast spurred 15% T2B membership growth.
All T2B members are subscribed to our newsletter and most follow us on LinkedIn. It's likely our community and broader brand following will see your org’s branding more than once, regardless if they attend.
Contact us at tickettobiotech@gmail.com to reserve your T2Bmeet sponsorship.Remember, you don’t have to be a T2B member to sponsor, to spread the word, or to follow along on LinkedIn!
T2B Monthly
Sign up for our monthly email update to see what we're hearing from the community. T2B membership not required.
© 2024 Ticket to Biotech. All rights reserved.
T2B PRIVACY POLICY
WHO T2B IS FOR
Public / media relations and external communications
Corporate and/or public affairs
Integrated communications
Marketing communications
Internal communications
Strategic communications
Visual storytellers and graphic designers
Aspiring biopharma communicators
The following are ineligible for T2B Slack community participation, but are welcome to follow us on LinkedIn:
In-house recruiters / TA and recruitment agencies
Reporters / bloggers
Service providers outside PR agencies and consultants
Anyone else trying to directly sell something or get leads
JOIN THE CONVO
Ticket to Biotech Slack workspace channels provide a variety of ways to participate. Join one or join them all!
#announcements
We curate snapshots, which we also post to LinkedIn. Topics include: recent #hot-topics takeaways, new #resources, and new job openings for #talent.
#hot-topics
We seed ≥one topic per week. Ex: corporate social activism areas, hybrid working strategies, AI(!), cool internal tools having a moment… and more.
#water-cooler
Post those questions that you think are silly but that everyone is actually thinking about. Tell us what’s on your mind.
#resources
Our knowledge center. We post reports, Substack and LI posts that caught our eye, and home-grown content over time.
#talent
Share any biopharma comms job openings you have on your team or that you’ve seen somewhere on a public channel.
REGIONAL NETWORKING
A highly sought-after feature by the T2B community is the chance to connect with biopharma comms peers locally.The T2B Slack workspace offers dedicated networking channels for the three leading U.S. life science hubs:
San Francisco Bay Area
Greater Boston Area
San Diego (SoCal)
As the T2B community expands, we'll introduce more regional networking channels.
2024 Programming
This year's offerings are based on T2B community feedback, numerous conversations and our own past experience. We hope that at least one of these catches your eye and that you’ll stick around to engage as part of our burgeoning communicator community. Click below + follow us on LI and in Slack for details. All programming free and open to T2B community members. Request to join T2B here to engage and attend. Sign up for our T2B Monthly email updates here (T2B membership not required).💬 Weekly Community Discussion Topics
Timely topic tied to what’s happening in the news, an emerging industry trend, or an upcoming T2B event or resource release. We started these last year, and members have asked us to keep the discussion going! How it works:
- We seed a discussion topic ~each week in Slack with a corresponding LinkedIn post (with a video!) sharing the situation, our take and community questions
- One-question anonymous poll in Slack for quick engagement
- Roundup of key takeaways from discussion posted to Slack and LinkedIn🔥 Monthly Comm Convos
SME 1:1 fireside chat or moderated panel highlighting biopharma comms interest areas. How it works:
- Vetted expert shares perspective and practical tips, followed by open Q&A
- Speakers will be a combination of folks from industry and people we love and admire beyond biopharma, to bring the outside in
- Log into Slack for recordings of February's Comm Convo, “Op-Ed Edge With Jake Meth"; March's Comm Convo, "Patient-Focused Comms With Jen Helfer"; April's Comm Convo, “Service-Driven Success With Sarah MacDonald, of Life Science Cares”; and May's Comm Convo, "Navigating the Biopharma Comms Hiring Landscape With Alma Villaseñor Hembree." Stay tuned for our next Comm Convo on June 11th, details TBA!🎙️ NEW AMA Series
Reddit-style Ask Me Anything series on our private T2B Slack workspace with various thought leaders. How it works:
- Our inaugural session was in April, when Scott White, a seasoned recruiter, answered questions, from strategizing career moves to unlocking the power of professional networks.
- Stay tuned for future AMAs. Our next AMA is coming in June!
- After registering and confirmation of your T2B community membership, we'll add you to our new #ama channel in Slack.🌐 Annual Peer-Learning Practicum
Peer-coaching group model enables communicators with diverse focus areas and experience levels to find unique value from each other and network on a deeper level. How it works:
- Virtual program opens participation opp to communicators globally and at all levels
- Ties into monthly Comm Convo focus area for a seamless experience
- 2024 PLP registration closed✨ Monthly Pulse Narratives
Series shines a light on the diverse and dynamic professionals in the T2B community, facilitating new connections. How it works:
- Participants select favorite topics from robust question bank
- Each Narrative covers background, deep dive on biopharma comms expertise, experience with T2B, and a fun fact, motto or quote; first edition here
- Nominations (self-nominations OK, too!) now open📰 Monthly Biopharma Beats Bulletins
Helping beat reporters help T2B members -- spotlight resulting in short, action-oriented guide for T2B members. How it works:
- Requested by T2B members as a high value-add resource
- Bulletin posted to Slack covers the profiled journalist’s background, beat overview, what they’re watching, pitching tips, pet peeves, events/conferences they plan to attend, and a key quote
- Profiled journalists include GEN's Alex Phillipidis, C&EN's Rowan Walrath, BioSpace's Jef Akst, and DD&D's Brian Buntz (full guides in T2B Slack)🎤 ~Quarterly Press Pass Panels
Following successful Pre-JPM Press Pass panel, we’re bringing this back, by popular demand! Moderated panels where reporters share their candid take and best practices. How it works:
- Bring together several top reporters for interactive virtual session
- Potential topics include opinion, high science, financial, and consumer🤝 T2Bmeets
Free industry event companion meet-ups.
- Lots of fantastic energy at our first one at JPM ‘24.
- Registration now open for T2Bmeet @ BIO! This come-and-go networking breakfast is free and open to all T2B community members. Whether you're based in SoCal or visiting for BIO, we hope to see you on June 4th in San Diego!📇 T2B Member Directory
New resource coming soon capturing T2B members’ existing contact info and background. Directory will maximize community connections for networking, learning, and job searching.
Press Pass to JPM highlights reel... Stay tuned for 2024 panels
T2B SLACK GUIDELINES
Chatham House Rule – sort-of.
We totally get that Slack = putting things in writing, but we ask all community members to go by the honor code: OK to cite (but not attribute) examples and ideas in your internal company discussions. No screenshots or mentions on external channels without prior permission from the community contributor.
No solicitations or ads for services.
Period. This includes no “open to work” or resume posting. If you see a job you want to apply for in the #talent channel, contact the person who posted it directly.
GET CONNECTED
After we verify your participation eligibility, you’ll receive a confirmation email with a direct link to the T2B workspace. You'll also be eligible to register for upcoming T2B programming.If you haven’t used Slack before, visit Slack.com to create a free account. You can easily access Slack in several ways:
In your internet browser
On the go using the iPhone app or Android app
Remember to follow us on LinkedIn
© 2024 Ticket to Biotech. All rights reserved.
T2B PRIVACY POLICY
TICKET TO BIOTECH (T2B) PRIVACY POLICY
1. IntroductionWelcome to Ticket to Biotech (T2B). We respect your privacy and are committed to protecting your personal data. This privacy policy will inform you about how we look after your personal data when you apply to join our community and tell you about your privacy rights and how the law protects you.---2. Important Information and Who We ArePurpose of this Privacy PolicyThis privacy policy aims to give you information on how T2B collects and processes your personal data when you apply to join our community.ControllerTicket to Biotech is the controller and responsible for your personal data.---3. The Data We Collect About YouWe may collect, use, store, and transfer different kinds of personal data about you which you have provided to us including:- LinkedIn profile link for validation purposes.
- Email for T2B community updates.
- T2B Slack workspace messages in public channels.---4. How We Use Your Personal DataWe will only use your personal data for the purpose for which we collected it which include the following:- To validate your eligibility to join the T2B community.
- To send you an automated email from "Slack" inviting you to the T2B Slack workspace.
- To send you a separate welcome email from T2B.
- To provide T2B community updates from time to time.---5. Disclosures of Your Personal DataBy signing up to the Ticket to Biotech community, participants acknowledge that we may, in the future, share their email addresses with T2B partners for collaborative and promotional purposes. Apart from this, we may share your personal data with third parties where required by law, where it is necessary to administer the working relationship with you, or where we have another legitimate interest in doing so.---6. Data SecurityWe have put in place appropriate security measures to prevent your personal data from being accidentally lost, used, or accessed in an unauthorized way, altered, or disclosed. In addition, we limit access to your personal data to those employees, agents, contractors, and other third parties who have a business need to know.---7. Data RetentionWe will only retain your personal data for as long as necessary to fulfill the purposes we collected it for, including for the purposes of satisfying any legal, accounting, or reporting requirements.---8. Your Legal RightsUnder certain circumstances, you have rights under data protection laws in relation to your personal data. These include the right to:- Request access to your personal data.
- Request correction of your personal data.
- Request erasure of your personal data.
- Object to the processing of your personal data.
- Request restriction of processing your personal data.
- Request transfer of your personal data.
- Right to withdraw consent.---9. Changes to the Privacy Policy and Your Duty to Inform Us of ChangesWe keep our privacy policy under regular review. This version was last updated on September 1, 2023. It is important that the personal data we hold about you is accurate and current. Please keep us informed if your personal data changes during your relationship with us.---10. Contact DetailsIf you have any questions about this privacy policy or our privacy practices, please contact:Community curator: Lynnea Olivarez
Email: tickettobiotech@gmail.com---By applying to join the Ticket to Biotech community, you acknowledge that you have read and understood this Privacy Policy.
© 2024 Ticket to Biotech. All rights reserved.
T2B PRIVACY POLICY
Press Pass to JPM: A Pre-Conference Conversation with Top Reporters
T2B's inaugural event is designed specifically for biopharma communicators! As we gear up for the JP Morgan Healthcare Conference (JPM) in January, it's time to delve deeper into the journalistic perspectives that shape our industry's narratives.📅 Date: Tuesday, November 28th
🕐 Time: 1-2 p.m. ET
📍 Location: VirtualOpen to all T2B community members, this is a panel with life science journalists and JPM veterans, Allison DeAngelis (STAT), Emily Mullin (Wired), and Gwendolyn Wu (BioPharma Dive). We'll explore their intended focus areas at JPM '24, the trends that will pique their interest for next year, and the sources and expertise they're looking for. We've scheduled this event to aid the T2B communicator community in forging meaningful connections with reporters right when outreach for JPM interactions begins.
WHY ATTEND?
Gain exclusive insights into the journalistic focal points for the upcoming JPM.
Understand the trends and topics that will dominate life science reporting in 2024.
Discover the companies and expertise journalists are eager to engage with.
Strategize your outreach effectively by knowing who to target for JPM meetings.
SPEAKERS
Allison DeAngelis is a biotech reporter at STAT, covering biopharma startups and venture capital. Prior to joining STAT, Allison covered the drug industry at Insider and the Boston Business Journal. She was named the Washington Newspaper Publishers Association's News Writer of the Year in 2016. She is based in Boston.
Emily Mullin is a staff writer at WIRED, covering biotechnology. Previously, she was an MIT Knight Science Journalism project fellow and a staff writer covering biotechnology at Medium's OneZero. Before that, she served as an associate editor at MIT Technology Review, where she wrote about biomedicine. Her stories have also appeared in National Geographic, Scientific American, Smithsonian Magazine and The Washington Post, among other outlets. She has a master's degree in science writing from Johns Hopkins University.
Gwendolyn Wu is a reporter at BioPharma Dive covering biotech startups, venture capital and the ecosystem that supports them. Previously, she authored Bay Briefing, the San Francisco Chronicle’s flagship weekday newsletter, and covered COVID-19 and the business of healthcare for the Houston Chronicle. Outside of the newsroom, Gwendolyn co-directs the AAJA Young Professionals Network, and teaches at the California Scholastic Press Association summer workshop. She has degrees in history and sociology from the University of California at Santa Barbara.
REGISTRATION CLOSED
Thank you for your interest in T2B! Join our community by requesting an invite via the link below. Gain access to a recording of this event and be the first to know about future programming.
© 2024 Ticket to Biotech. All rights reserved.
T2B PRIVACY POLICY
Join us to kick off T2B's 2024 Comm Convo series, where we'll have candid, monthly 1:1 conversations with top-notch comms experts. During each fireside chat, we'll pull back the curtain on a specific topic to inform your own life sci comms strategies. We'll also devote a section of every Comm Convo for open audience Q&A.
Op-Ed Edge: Crafting Compelling Narratives with Jake Meth
February's Comm Convo features Jake Meth, founder of op-ed consultancy Opinioned and former editor of commentary at Fortune magazine. He'll share his insights on spotting opportunities for impactful op-eds and bylined articles, emphasizing the importance of a unique point of view in the crowded biopharma landscape. Get his take on how to craft narratives that not only inform but also influence, and learn practical strategies for pitching them to top-tier editors effectively.📅 Date: Tuesday, February 6th
🕐 Time: 1-2 p.m. ET
📍 Location: VirtualFor more on Jake’s approach to op-ed success, check out his free "Pitches Get Stitches" newsletter.
WHY ATTEND?
Gain first-hand knowledge from Jake, leveraging his experience as a top-tier editor to elevate your op-ed strategy.
Learn how to identify and articulate perspectives that make your op-eds stand out in the biopharma sector.
Understand how to integrate op-eds into a broader thought leadership program, enhancing your brand’s influence.
Hear Jake's tips for pitching and landing your pieces with leading publications, beyond the typical trade press.
Meet Our SPEAKER
Jake Meth started Opinioned because he wanted to see more original ideas in the media after spending five years building and editing Fortune magazine’s commentary section.Drawing on his editorial leadership experience, Jake founded Opinioned and now guides various industry leaders -- and communicators like us at T2B -- in shaping thought leadership programs with narratives that resonate on a global stage.Jake started in journalism after graduating from college, when he moved to Egypt for two years to cover the Arab Spring uprising for a local newspaper. Following that, he relocated to New York and worked in media relations for Foreign Affairs magazine and the Council on Foreign Relations.Jake received the 2020 New York Press Club award for excellence in journalism in the magazine consumer reporting category for his Fortune investigation into the epidemic of laundry pod poisonings among young children.He lives in Jersey City, NJ., and enjoys doing improv, eating good food and being a plant dad.
Registration Closed
Thank you for your interest in T2B! Join our community by requesting an invite via the link below. Gain access to a recording of this event and be the first to know about future programming.
Interested in sponsoring?
Comprehensive sponsorship tracks are in the works, but in the interim, we’re making available a one-time only opp to sponsor our February programming a la carte. There are limited sponsorships available for this February Comm Convo and other offerings. Help us keep programming free this year!
© 2024 Ticket to Biotech. All rights reserved.
T2B PRIVACY POLICY
Patient-Focused Comms: Engagement Narratives With Jen Helfer
Integrating the patient perspective into communications in our industry is critical, but can sometimes be overlooked amid scientific jargon and earnings reports. Jen Helfer, patient advocacy extraordinaire, will guide communicators during March's Comm Convo on authentically incorporating the patient voice in our work, from internal communications to public-facing content.📅 Date: Wednesday, March 6th
🕐 Time: 2-3 p.m. ET
📍 Location: Virtual
WHY ATTEND?
Identify ways to authentically introduce the patient perspective into communications strategies to yield narratives that are resonant and patient-centric.
Discover best practices for adapting corporate messaging and materials to reflect patient experiences accurately and effectively.
Gain insight on the preparation and ethical considerations for patient involvement in corporate materials and media pitching.
Uncover strategies to engage patient communities in enhancing employee understanding and connection.
Equip your comms team with practical approaches to navigate the initial steps in patient community engagement – with or without an in-house, dedicated patient advocacy function.
Meet Our SPEAKER
Jen Helfer is passionate about meaningfully engaging patient communities to improve therapeutic development and delivery of healthcare. She has a strong background in the pharmaceutical industry, patient advocacy non-profit, and bench research.Currently she is head of patient advocacy and engagement at a late-stage biopharmaceutical company. Previously, Jen held roles at Encoded Therapeutics, VOZ Advisors, bluebird bio, and the National Brain Tumor Society.Jen also serves as a Board Member of the Massachusetts Sickle Cell Association, Scientific and Patient Advocacy Advisor to CureGSD1b Alliance, Faculty of the Professional Patient Advocates in Life Sciences, and Member of ASGCT's Patient Outreach Committee.Follow Jen on LinkedIn.
Registration Closed
Thank you for your interest in T2B! Confirm your eligibility, and join our community via this link to view a recording of this event and access future programming.
About T2B Comm Convos
In T2B's 2024 Comm Convo series, we have candid, monthly 1:1 conversations with top-notch comms experts. Speakers are a combination of folks from industry and people we love and admire beyond biopharma, to bring the outside in. During each fireside chat, we pull back the curtain on a specific topic to inform your own life sci comms strategies. We also devote a section of every Comm Convo for open audience Q&A.
© 2024 Ticket to Biotech. All rights reserved.
T2B PRIVACY POLICY
Service-Driven Success: Communicating for Impact With Sarah MacDonald
Join us in April, during National Volunteer Month, for a Comm Convo with Sarah MacDonald, CEO of Life Science Cares. With a foundation in journalism and public affairs, Sarah exemplifies how storytelling and effective communication drive success in both leadership and philanthropy within the biopharma industry.This discussion will focus on the practical application of these skills to enhance corporate engagement with communities, energize employees, and build meaningful connections. Sarah will share her journey building LSC from the ground up, the insights gained from collaborating with C-suite leaders across major life science hubs, and the significance of integrating community service into biopharma's business model, even for companies without formal corporate social responsibility (CSR) programs.📅 Date: Wednesday, April 3rd
🕐 Time: 1-2 p.m. ET
📍 Location: Virtual
WHY ATTEND?
Understand the role of communications and storytelling in promoting community engagement and supporting social impact initiatives, highlighting the importance for biopharma companies of all sizes.
Explore how service-driven strategies can enrich professional development, improve company culture, and strengthen industry-community ties, drawing on Sarah’s experience and insights from C-suite leaders.
Identify practical ways to incorporate volunteering and social responsibility into corporate practices, emphasizing the impact on health equity and the broader societal value.
Meet Our SPEAKER
Sarah MacDonald is the CEO of Life Science Cares, a nonprofit organization dedicated to eliminating the impact of poverty by leveraging the financial resources of life science companies in five locations: Boston, Philadelphia, San Diego, the San Francisco Bay Area and New York. Prior to joining Life Science Cares, Sarah served as Executive Vice President at MassBio, the life science industry trade association, where she led policy, communications, events, and strategy of the 1,000+ member company organization.Before MassBio, Sarah held several association and policy positions, including Interim Executive Director of the Massachusetts Pharmacists Association and as Deputy Chief of Staff in the Department of Business Development for the Commonwealth of Massachusetts.Sarah is a graduate of Hartwick College and has a Master’s degree from Northeastern University.Follow Sarah on LinkedIn.
REGISTRATION CLOSED
Thank you for your interest in T2B! Confirm your eligibility, and join our community via this link to view a recording of this event and access future programming.
About T2B Comm Convos
In T2B's 2024 Comm Convo series, we have candid, monthly 1:1 conversations with top-notch comms experts. Speakers are a combination of folks from industry and people we love and admire beyond biopharma, to bring the outside in. During each fireside chat, we pull back the curtain on a specific topic to inform your own life sci comms strategies. We also devote a section of every Comm Convo for open audience Q&A.
© 2024 Ticket to Biotech. All rights reserved.
T2B PRIVACY POLICY
Navigating the Biopharma Comms Hiring Landscape With Alma Villaseñor Hembree
Despite an increase in comms jobs coming on the market in Q1, there are still more qualified candidates than there are available roles. As a senior global executive recruiter for some of the most well-known companies in our industry, Alma Villaseñor Hembree will give us a look under the hood of the competitive biopharma comms/PR landscape. This session is designed for communicators across all career stages, from those exploring new opportunities to veterans guiding the next generation of talent. With Alma, we’ll delve into the nuances of hiring practices, cultural fit, executive presence, unconscious biases and more.📅 Date: Thursday, May 2nd
🕐 Time: 1-2 p.m. ET
📍 Location: Virtual
WHY ATTEND?
Learn how to read between the lines of job listings and titles, identifying cues that can influence career paths or inform job descriptions.
Gain a clearer understanding of the qualities that make candidates stand out, including the unspoken subtleties of executive presence and cultural fit.
Discuss strategies to recognize and counteract biases in the hiring process, enhancing fairness and inclusivity across our profession.
Explore how networking and ongoing professional development can advance your career or position yourself as a sector leader.
Reflect on changes and upcoming trends in biopharma comms hiring, preparing for the evolving demands and opportunities in the industry.
Meet Our SPEAKER
Alma Villaseñor Hembree is a senior global talent solutions consultant within pharmaceuticals and biotechnology, with a background in Commercial & Market Access Analytics. She's passionate about healthcare and in finding the best people to impact organizations and drive patients' access to the medicines they need.Alma's main areas of expertise span executive-level search in the Commercial (Sales, Marketing, Market Access, Medical Affairs (Scientific Communications, Publications, MSL's)) and Corporate Support functions (Finance, Corporate Affairs, Business Development, Legal, HR, Analytics, IT, etc.), and R&D (Clinical Development & Operations, Clinical Pharmacology, Pharmacovigilance). Her remit spans the US, Europe, India, China, and Japan.Follow Alma on LinkedIn.
Comm Convo Registration Closed
Thank you for your interest in T2B! Confirm your eligibility, and join our community via this link to view a recording of this event and access future programming.
About T2B Comm Convos
In T2B's 2024 Comm Convo series, we have candid, monthly 1:1 conversations with top-notch comms experts. Speakers are a combination of folks from industry and people we love and admire beyond biopharma, to bring the outside in. During each fireside chat, we pull back the curtain on a specific topic to inform your own life sci comms strategies. We also devote a section of every Comm Convo for open audience Q&A.
© 2024 Ticket to Biotech. All rights reserved.
T2B PRIVACY POLICY
T2Bmeet @ JPM
Join us for our first live T2Bmeet! This come-and-go continental breakfast is free and open to all T2B community members.📅 Date: Monday, January 8th
🕐 Time: 6:30-9:30 a.m. PT
📍 Location: BlueStream Gallery, 555 Grant Avenue, SF 94108
(10-minute walk from the Westin St. Francis)Whether you're based in the Bay Area or visiting for JPM, we hope to see you there.
REGISTRATION
Thanks to everyone who attended our event! Stay tuned for more great programming in 2024.
About the Venue
BlueStream Gallery opened in 2023 in Chinatown and focuses on contemporary art. Their goal is to convey the beauty of art to the public with in-depth works and to provide new and diverse opportunities for artists through participation in domestic and foreign art fairs. BlueStream aims to become a gallery that grows and develops with artists.
© 2024 Ticket to Biotech. All rights reserved.
T2B PRIVACY POLICY
This come-and-go continental breakfast is free and open to all T2B community members. Whether you're based in SoCal or visiting for BIO, we hope to see you there.📅 Date: Tuesday, June 4th
🕐 Time: 7-10 a.m. PT
📍 Location: 2031 Commercial St, San Diego, CA 92113BIO International Convention registration not needed, but advance breakfast signup is required. If you're new to T2B, first confirm that you're eligible and fill out this form to join our community.
Click here for more info on sponsoring T2Bmeet @ BIO.
Our venue is a 20-minute walk or 10-minute drive to the San Diego Convention Center. There is free street parking located on both sides of Commercial Street, as well as limited spots on both sides of the building.
© 2024 Ticket to Biotech. All rights reserved.
T2B PRIVACY POLICY